Fosun Pharma paves way for Henlius spin-off
Shanghai Fosun Pharmaceutical Group is looking to spin off its biotechnology unit through a Hong Kong IPO.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: